James Ballard, MD
Vascular Surgery · Bend, ORNPI 1134324528
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,266 of the $14,774 with a category attached, or 62.7%. It is spread thinly across 25 manufacturers, the largest accounting for just 21.7%. Reporting peaked in 2021 at $4,555 and has fallen 50.4% since, to $2,260 in 2025.
Across 212 payments — averaging $69.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$3K
- Boston Scientific$2K
- Silk Road Medical, Inc.$2K
- W. L. Gore & Associates, Inc.$1K
- Inari Medical, Inc.$1K
- Penumbra, Inc.$1K
- plus $4K from 19 others
What the payments were for
- Consulting fees$2902%
- Travel & lodging$2,03114%
- Food & beverage$9,26663%
- Education$3,18822%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 2 | $3,211 |
| Boston Scientific | 66 | $2,290 |
| Silk Road Medical, Inc. | 42 | $1,843 |
| W. L. Gore & Associates, Inc. | 15 | $1,445 |
| Inari Medical, Inc. | 5 | $1,390 |
| Penumbra, Inc. | 8 | $1,046 |
| Zimmer Biomet | 17 | $850 |
| Endologix LLC | 10 | $612 |
| Medtronic(2 entities) | 9 | $571 |
| Cook Medical LLC | 6 | $410 |
| Johnson & Johnson | 12 | $319 |
| Stryker | 2 | $243 |
| Cagent Vascular Inc | 1 | $158 |
| Bolton Medical Inc | 1 | $84 |
| Abbott | 3 | $62 |
| Shockwave Medical, Inc | 2 | $36 |
| Pfizer | 2 | $31 |
| KCI USA, Inc. | 2 | $29 |
| Acera Surgical, Inc. | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $25 |
| Bard Peripheral Vascular, Inc. | 1 | $24 |
| Merit Medical Systems Inc | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| Surmodics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$3,188
- FLOWTRIEVER CATHETER, S$1,332
- CT THROMBECTOMY SYSTEM KIT$1,332
- ENROUTE Transcarotid Neuroprotection System$1,052
- ENHANCE Transcarotid Peripheral Access Kit$1,052
- ENROUTE Transcarotid Stent System$949
- ENROUTE 0.014 Guidewire$949
- Indigo System$532
- Penumbra System$377
- Product in Development$290
- ENROUTE Transcarotid Stent$205
- GORE EXCLUDER AAA Endoprosthesis$175
- ARTIX MT$170
- ENDURANT IIS$167
- Serrantor$158
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$157
- CoreValve Evolut$156
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$150
- Cook$145
- RUBY Coil$137
How this compares
$14,774 in reported general payments places this provider in the 75th percentile of 56 vascular surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 37 | $51,166 |
| EliquisApixaban | 34 | $39,548 |
| ClopidogrelClopidogrel Bisulfate | 275 | $3,618 |
| Cilostazol | 41 | $1,058 |
| Atorvastatin Calcium | 51 | $653 |
| Rosuvastatin Calcium | 14 | $346 |
| Pantoprazole Sodium | 14 | $147 |
| Oxycodone Hcl | 34 | $51 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $319 | $51,16637 claims |
| PfizerEliquis | $31 | $39,54834 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 56 vascular surgery providers in Oregon.
Other vascular surgery in Bend
- Wayne NelsonBend$69K
- Paul LongBend$62K
- Jason JundtBend$15K
- John WiestBend$2K
- Brant UlleryWilsonville$816K
- Mark MoraschSpringfield$127K
- Cherrie AbrahamPortland$80K
- Jeffrey CrawfordCorvallis$46K
- Craig SeidmanSpringfield$20K
- John DusselWilsonville$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.